Following Wegovy’s arrival in Israel, the Health Ministry has today instructed pharmacists nationwide to cease selling Ozempic for weight loss, limiting its use to diabetes patients only. Those who have begun using Ozempic for weight loss are advised to gradually transition to Wegovy. The frenzy over Ozempic in Israel began a little over two years […]
Continue Reading
Since the October 7 massacre, many victims have been struggling with their mental health. It is now evident that the trauma of war and security tensions have led to an increase in the use of narcotics. According to a recent survey conducted by Maccabi Healthcare Services, 56% of smokers reported that their cigarette use increased […]
Continue Reading
Mushrooms help make a great salad or omelet but, amazingly, they may also improve mental health – from depression to post-traumatic stress disorder (PTSD) to schizophrenia – according to a new study conducted at Jerusalem’s Hebrew University-Hadassah Medical Center. The research, led by doctoral student Orr Shahar and Dr. Alexander Botvinnik, under the guidance of […]
Continue Reading
Further progress has been recorded in the fight against AIDS. GSK reported that it had completed its phase one trial of a new drug to prevent HIV infection, which will be given as part of the PrEP protocol, and may replace the need to take pills on a daily basis. About 9,000 HIV carriers live […]
Continue Reading
Nice Guy, also known as the “designer drug,” is a popular and dangerous drug in Israel. Researchers at Rambam Health Care Campus in Haifa have discovered a new method to diagnose victims of its potentially lethal poisoning through CT imaging, allowing for quick identification and life-saving treatment. The research findings have been published in the medical […]
Continue Reading
An American-Israeli immunomics company has announced another success in supporting a major pharmaceutical company in moving its drugs from the lab to clinical approval, The Jerusalem Post has learned. “With our partners, we have succeeded in meeting agreed-upon deliverables,” said Noam Solomon, CEO of Immunai. “In the past two years, we have had a handful […]
Continue Reading
Elon Musk has been worrying executives at two of his enterprises, who are concerned over the Billionaire’s use of illegal drugs, the Wall Street Journal published on Saturday. The Journal reported that some people close to the 52-year-old are afraid that the drugs might pose a risk to Musk’s health and the health of Musk’s […]
Continue Reading
